Imugene

Perth biotechnology company Imugene Ltd has received notice of grant for patent protection for its Porcine Adenoviral Delivery Vector technology in the United States of America, the company has announced.

Arafura Resources Ltd has been awarded a $3.3 million federal government grant for its NT rare earths-uranium project while biotechnology company Imugene Ltd has secured an $880,000 grant to produce and test bird flu vaccines on chickens.

WA-based biotechnology company Imugene Ltd has won exclusive distribution rights for its porcine adenoviral vector delivery system, after success in a hearing administered by the US patent office.

Biotechnology company Imugene said it has achieved “one of its biggest regulatory milestones” with a licence for the limited release of its poultry productivity enhancer (PPE).

ANIMAL vaccine developer Imugene has finalised a $5 million share placement it announced on November 23.

24-Nov-04Portfolio Partners Ltd became a substantial shareholder with a relevant interest of 10,649,647 ordinary shares (9.83%).

VETERINARY health company Imugene has been granted a key patent in Japan for the product that is the basis of its poultry vaccines.

PHARMACEUTICAL company Imugene has become a direct competitor to Chemeq after licensing a new technology developed at the University of Adelaide.